A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors

NCT07141706 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

233

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced/Metastatic Solid Tumors

Interventions

DRUG: DB-1317

Sponsor

DualityBio Inc.